CORRECTION FROM SOURCE: Bio-Solutions Corp. Announces the Fast Marketing of a Second Organic Product to Counter Malaria

MONTREAL, CANADA, Jul 10 (MARKET WIRE) --
Bio-Solutions Corp. (OTCBB: BISU) will market new and very effective
organic product to counter Malaria; GreenEx(TM). Malaria is the forefront
of priorities for the World Health Organization. GreenEx(TM) is an
organic insecticide available in solid or liquid form which neutralizes
and eradicates up to 98% of the larvae, within only 24 hours. Malaria is
the most dangerous disease transmissible by mosquitoes that we know of.

Each year, over 250 million people are infected and more than one million
children under the age of five years die by cause of Malaria. "This
organic product can be as useful in veterinary care as for human car;
Bio-Solutions will advocate a specialized market strategy for
GreenEx(TM). We will offer this product as a viable alternative to the
countries dissatisfied of the service offered by the multinationals. In
certain cases, the demands in services and products are too small to
interest these large corporations, which is not our case" indicated Dr.
Gilles Chaumillon PhD/MBA, CEO of Bio-Solutions Corp.

The Malaria related market represents several hundreds of million dollars
in all the forms of products used against this disease. Bio-Solutions
thus integrates in its portfolio, a product representing a large revenue
potential. Malaria is an endemic disease in the tropical zones of the
Americas, Asia, and most regions of Africa. However, Sub-Saharan Africa
accounts for 85% to 90% of deaths (mostly children under the age of five
years and pregnant women).

"We will propel the marketing of this product by the valorization of our
international network and we will be able to quickly generate income for
our company", indicated Dr. Gilles Chaumillom. "Bio-Solutions Corp can
offer turn-key services to the countries affected by these difficult
problems or to work out in partnership for swift strategic interventions
with these countries at the scientific and business levels", added Dr.
Gilles Chaumillon.

For more information on Bio-Solutions Corp. and its products, please
visit the company's website at www.bio-solutionscorp.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to
the safe harbour provisions of the U.S. Securities Litigation Reform Act
of 1995. Forward-looking statements involve known and unknown risks and
uncertainties, which could cause the Bio-Solutions' actual results to
differ materially from those in the forward-looking statements. Such
risks and uncertainties include, among others, the availability of funds
and resources to pursue R&D projects, the successful and timely
completion of studies, the ability of the Company to take advantage of
business opportunities in the biotechnology industry, uncertainties
related to the regulatory process and general changes in economic
conditions. Investors should consult the Company's quarterly and annual
filings with the U.S. securities commissions for additional information
on risks and uncertainties relating to the forward-looking statements.
Investors are cautioned not to rely on these forward-looking statements.
The Company does not undertake to update these forward-looking statements
and disclaims any obligation to update any such factors or to publicly
announce the result of any revisions to any of the forward-looking
statements contained herein to reflect future results, events or
developments, except if we are requested by a governmental authority or
applicable law.

Contacts:
ONZ Communications
Selam Tewolde
514-567-0282
selam@onzcom.com

Copyright 2009, Market Wire, All rights reserved.

-0-